ClinicalTrials.Veeva

Menu

DERCOS DS DANDRUFF TREATMENT OBSERVATIONAL STUDY 2022

C

Cosmetique Active

Status

Completed

Conditions

Dandruff

Treatments

Other: Dermocosmetic product: Selenium Disluphide Shampoo (Dercos DS)

Study type

Observational

Funder types

Industry

Identifiers

NCT05989633
Dercos DS in Dandruff

Details and patient eligibility

About

The aim of this study is to evaluate the satisfaction / tolerance / cosmeticity of Dercos DS

Enrollment

5,131 patients

Sex

All

Ages

12+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with dandruff or seborrheic dermatitis
  • All hair types
  • All ethnicities (Asian, Caucasian, Afro-American, African, Hispanic)
  • Including patients with specific occlusion habits (for instance veil use at least 8 hours per day, hat use)
  • Patients willing to provide written informed consent

Exclusion criteria

  • Under 12 years old
  • Pregnancy, breast feeding, childbearing potential without adequate contraception, or irregular menstrual cycles.
  • History of allergy, anaphylaxis or hypersensitivity to any of the ingredients of Shampoo any of the ingredients of DERCOS ANTI-DANDRUFF normal to oily hair shampoo
  • History of allergic contact dermatitis secondary to shampoo, conditioner, mask, and/or leave-in.
  • Has any clinical manifestations in the treatment(s) or other disorders that, in the opinion of the investigator, may affect the evaluations or results of the study products.- Inability to stay the study period (56 days +-5 days) without performing any hair/scalp procedure, including coloring, straightening and cutting.
  • Inability to attend all study visits and follow treatment regimen

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems